Education

Fellowship
UCLA GIM and Health Services Research, 2005
Residency
Internal Medicine, New York University School of Medicine, 2002
Internship
Internal Medicine, New York University School of Medicine, 1999
Degree
MD, Stanford University School of Medicine, 1993

Medical Board Certifications

Internal Medicine
American Board of Internal Medicine, 2001

Gender

Male

State License

A79201
  • About Me

    About Me

    UCLA Center for Behavioral and Addiction Medicine (CBAM), Medical Director

    Links

  • Locations

    UCLA Family Center Center

    (primary location)
    Address
    1920 Colorado Avenue
    Santa Monica, California 90404
    Phone
    310-319-4700
  • Education

    Medical Board Certifications

    Internal Medicine
    American Board of Internal Medicine, 2001

    Education

    Fellowship
    UCLA GIM and Health Services Research, 2005
    Residency
    Internal Medicine, New York University School of Medicine, 2002
    Internship
    Internal Medicine, New York University School of Medicine, 1999
    Degree
    MD, Stanford University School of Medicine, 1993
  • Research

    Research Interest

    Addiction Medicine in Primary Care; Development of Anti-Addiction Medications; Clinical Trials

    Publications

    Bluthenthal RN, Heinzerling KG, Martinez A, Kral AH. Police Crackdowns, Societal Cost, and the Need for Alternative Approaches. International Journal of Drug Policy, Volume 16, Issue 3, pages 137-138, June 2005.

    Heinzerling KG, Kral AH, Flynn NM, Anderson RL, Scott A, Gilbert ML, Asch SM, Bluthenthal RN. Unmet Need for Recommended Preventive Health Services Among Clients of California Syringe Exchange Programs: Implications for Quality Improvement. Drug and Alcohol Dependence, Volume 81, Number 2, pages 167-178, February 1, 2006.

    Heinzerling KG, Etzioni DA, Hurley B, Holtom P, Bluthenthal RN, Asch SM. Hospital Utilization for Injection Drug Use-Related Soft Tissue Infections in Urban Versus Rural Counties in California. Journal of Urban Health, Volume 83, Number 2, pages 176-181, March 2006. Heinzerling KG, Shoptaw S, Peck JA, Yang X, Liu J, Ling W. Randomized, Placebo-Controlled Trial of Baclofen and Gabapentin for the Treatment of Methamphetamine Dependence. Drug and Alcohol Dependence, Volume 85, Number 3, pages 177-184, December 1, 2006.

    Heinzerling KG, Kral AH, Flynn NM, Anderson RL, Scott A, Gilbert ML, Asch SM, Bluthenthal RN. HIV and Hepatitis C Testing at Syringe Exchange Programs: Availability and Outcomes, Journal of Substance Abuse Treatment, Volume 32, Number 4, pages 423-429, June 2007.

    Bluthenthal RN, Heinzerling KG, Gilbert ML, Anderson R, Flynn NM, Scott A, Kral AH. Legalization of syringe exchange programs in California: Mixed results from a local approach to HIV prevention. American Journal of Public Health, Electronic Publication, May 30, 2007.

    Shoptaw S, Heinzerling KG, Rotheram-Fuller E, Kao UH, Wang PC, Bholat M, Ling W. Bupropion Hydrochloride Versus Placebo, in Combination with Cognitive Behavioral Therapy, for the Treatment of Cocaine Abuse/Dependence, Journal of Addictive Diseases, in press.

    Link to pubmed publications »

  • Videos
Keith Heinzerling, MD, click here to update your profile.